SCHEMBL4491901

SCHEMBL4491901

CCCCOc1cccc(S(=O)(=O)Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 2/20 0.51
TSHR P16473 2/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
TLR4 O00206 1/20 0.47
TLR2 O60603 1/20 0.47
KMT2A Q03164 2/20 0.47
LTA4H P09960 2/20 0.46
THRB P10828 1/20 0.46
PLA2G4B P0C869 2/20 0.45
SMPD1 P17405 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP19A1 P11511 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31195081 0.95 TSHR (0.54) KAT6ATSHRCA12CA1CA2
SCHEMBL16844514 0.86 KAT6A (0.43) KAT6ATSHRCA12CA1CA2
SCHEMBL31195113 0.86 MAPK1 (0.47) KAT6ATSHRSMPD1CYP1A2CYP2C19
SCHEMBL29971277 0.86 MAPK1 (0.47) KAT6ACYP1A2CYP2C19ALDH1A1GAA
SCHEMBL28711245 0.86 MAPK1 (0.47) KAT6ACYP1A2CYP2C19ALDH1A1GAA
SCHEMBL28716233 0.86 MAPK1 (0.47) KAT6ATSHRSMPD1CYP1A2CYP2C19
SCHEMBL3283827 0.85 TP53 (0.50) KAT6ACA12CA1CA2CA7
SCHEMBL27284282 0.84 HTR6 (0.44) KAT6ACYP1A2CYP2C19ALDH1A1
SCHEMBL24863830 0.84 F2 (0.41) ALDH1A1
SCHEMBL21501091 0.84 TSHR (0.54) TSHRCA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7528124-B2 1,3-dihydro-2H-indol-2-one derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-05-05 US disclosed
US-20060276449-A1 1,3-Dihydro-2h-indol-2-one derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1659121-A1 1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276449-A1 1,3-Dihydro-2h-indol-2-one derivative AVPR1B, AVPR2, AVPR1A KAT6A 3419/4885TSHR 85/4885CA12 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.